Cargando…
HBX-6, Standardized Cornus officinalis and Psoralea corylifolia L. Extracts, Suppresses Benign Prostate Hyperplasia by Attenuating E2F1 Activation
Background: The aim of this study was to simplify and identify the contents of the herbal formula, HBX-5. This study was carried out to evaluate the therapeutic effects of HBX-6 in a mouse model of benign prostatic hyperplasia (BPH). Based on in vitro, we selected a candidate, reconstituted an exper...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539643/ https://www.ncbi.nlm.nih.gov/pubmed/31052610 http://dx.doi.org/10.3390/molecules24091719 |
_version_ | 1783422438813466624 |
---|---|
author | Jin, Bo-Ram Kim, Hyo-Jung Seo, Jong-Hwan Kim, Myoung-Seok Lee, Kwang-Ho Yoon, Il-Joo An, Hyo-Jin |
author_facet | Jin, Bo-Ram Kim, Hyo-Jung Seo, Jong-Hwan Kim, Myoung-Seok Lee, Kwang-Ho Yoon, Il-Joo An, Hyo-Jin |
author_sort | Jin, Bo-Ram |
collection | PubMed |
description | Background: The aim of this study was to simplify and identify the contents of the herbal formula, HBX-5. This study was carried out to evaluate the therapeutic effects of HBX-6 in a mouse model of benign prostatic hyperplasia (BPH). Based on in vitro, we selected a candidate, reconstituted an experimental agent and investigated the effects on testosterone-induced BPH rats. Cell viability was determined by MTT assay in RWPE-1 and WPMY-1 cells. The expression of androgen receptor (AR) was measured in dihydrotestosterone-stimulated RWPE-1 and WPMY-1 cells. BPH was induced in mice by a subcutaneous injection of testosterone propionate for four weeks. Animals were divided into six groups: Group 1, control mice; Group 2, mice with BPH; Group 3, mice with BPH treated with finasteride; Group 4, mice with BPH treated with 200 mg/kg HBX-5; Group 5, mice with BPH treated with 100 mg/kg HBX-6; and Group 6, mice with BPH treated with 200 mg/kg HBX-6. Changes in prostate weight were measured after treatments, and the thickness of the epithelium was evaluated. The expression levels of proteins associated with prostatic cell proliferation and cell cycle-related proteins were determined. Based on previous reports and in vitro results, we selected Cornus officinalis and Psoralea corylifolia among HBX-5 components and reconstituted the experimental agent, and named it HBX-6. The result represented a new herbal formula, HBX-6 that suppressed the pathological alterations in BPH and showed a marked reduction in proliferation-related protein expression compared to mice with BPH. Our results indicate that HBX-6 has a better therapeutic effect in the BPH murine model than those of HBX-5 and finasteride, suggesting the role of HBX-6 as a new BPH remedial agent. |
format | Online Article Text |
id | pubmed-6539643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65396432019-05-31 HBX-6, Standardized Cornus officinalis and Psoralea corylifolia L. Extracts, Suppresses Benign Prostate Hyperplasia by Attenuating E2F1 Activation Jin, Bo-Ram Kim, Hyo-Jung Seo, Jong-Hwan Kim, Myoung-Seok Lee, Kwang-Ho Yoon, Il-Joo An, Hyo-Jin Molecules Article Background: The aim of this study was to simplify and identify the contents of the herbal formula, HBX-5. This study was carried out to evaluate the therapeutic effects of HBX-6 in a mouse model of benign prostatic hyperplasia (BPH). Based on in vitro, we selected a candidate, reconstituted an experimental agent and investigated the effects on testosterone-induced BPH rats. Cell viability was determined by MTT assay in RWPE-1 and WPMY-1 cells. The expression of androgen receptor (AR) was measured in dihydrotestosterone-stimulated RWPE-1 and WPMY-1 cells. BPH was induced in mice by a subcutaneous injection of testosterone propionate for four weeks. Animals were divided into six groups: Group 1, control mice; Group 2, mice with BPH; Group 3, mice with BPH treated with finasteride; Group 4, mice with BPH treated with 200 mg/kg HBX-5; Group 5, mice with BPH treated with 100 mg/kg HBX-6; and Group 6, mice with BPH treated with 200 mg/kg HBX-6. Changes in prostate weight were measured after treatments, and the thickness of the epithelium was evaluated. The expression levels of proteins associated with prostatic cell proliferation and cell cycle-related proteins were determined. Based on previous reports and in vitro results, we selected Cornus officinalis and Psoralea corylifolia among HBX-5 components and reconstituted the experimental agent, and named it HBX-6. The result represented a new herbal formula, HBX-6 that suppressed the pathological alterations in BPH and showed a marked reduction in proliferation-related protein expression compared to mice with BPH. Our results indicate that HBX-6 has a better therapeutic effect in the BPH murine model than those of HBX-5 and finasteride, suggesting the role of HBX-6 as a new BPH remedial agent. MDPI 2019-05-02 /pmc/articles/PMC6539643/ /pubmed/31052610 http://dx.doi.org/10.3390/molecules24091719 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jin, Bo-Ram Kim, Hyo-Jung Seo, Jong-Hwan Kim, Myoung-Seok Lee, Kwang-Ho Yoon, Il-Joo An, Hyo-Jin HBX-6, Standardized Cornus officinalis and Psoralea corylifolia L. Extracts, Suppresses Benign Prostate Hyperplasia by Attenuating E2F1 Activation |
title | HBX-6, Standardized Cornus officinalis and Psoralea corylifolia L. Extracts, Suppresses Benign Prostate Hyperplasia by Attenuating E2F1 Activation |
title_full | HBX-6, Standardized Cornus officinalis and Psoralea corylifolia L. Extracts, Suppresses Benign Prostate Hyperplasia by Attenuating E2F1 Activation |
title_fullStr | HBX-6, Standardized Cornus officinalis and Psoralea corylifolia L. Extracts, Suppresses Benign Prostate Hyperplasia by Attenuating E2F1 Activation |
title_full_unstemmed | HBX-6, Standardized Cornus officinalis and Psoralea corylifolia L. Extracts, Suppresses Benign Prostate Hyperplasia by Attenuating E2F1 Activation |
title_short | HBX-6, Standardized Cornus officinalis and Psoralea corylifolia L. Extracts, Suppresses Benign Prostate Hyperplasia by Attenuating E2F1 Activation |
title_sort | hbx-6, standardized cornus officinalis and psoralea corylifolia l. extracts, suppresses benign prostate hyperplasia by attenuating e2f1 activation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539643/ https://www.ncbi.nlm.nih.gov/pubmed/31052610 http://dx.doi.org/10.3390/molecules24091719 |
work_keys_str_mv | AT jinboram hbx6standardizedcornusofficinalisandpsoraleacorylifolialextractssuppressesbenignprostatehyperplasiabyattenuatinge2f1activation AT kimhyojung hbx6standardizedcornusofficinalisandpsoraleacorylifolialextractssuppressesbenignprostatehyperplasiabyattenuatinge2f1activation AT seojonghwan hbx6standardizedcornusofficinalisandpsoraleacorylifolialextractssuppressesbenignprostatehyperplasiabyattenuatinge2f1activation AT kimmyoungseok hbx6standardizedcornusofficinalisandpsoraleacorylifolialextractssuppressesbenignprostatehyperplasiabyattenuatinge2f1activation AT leekwangho hbx6standardizedcornusofficinalisandpsoraleacorylifolialextractssuppressesbenignprostatehyperplasiabyattenuatinge2f1activation AT yooniljoo hbx6standardizedcornusofficinalisandpsoraleacorylifolialextractssuppressesbenignprostatehyperplasiabyattenuatinge2f1activation AT anhyojin hbx6standardizedcornusofficinalisandpsoraleacorylifolialextractssuppressesbenignprostatehyperplasiabyattenuatinge2f1activation |